Federal contract award
HT942525P0023
DHA SBIR PHASE I FOR PROJECT TITLED, "DEXAMETHASONE NANOTHERAPEUTICS FOR TRAUMATIC BRAIN INJURY"
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $249.5K |
| Current contract value | $249.5K |
| Potential contract value / ceiling | $249.5K |
| Start date | Jan 27, 2025 |
| Current end date | Sep 2, 2025 |
| Potential end date | Sep 2, 2025 |
| Latest award activity | Apr 1, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 1, 2025 | P00001 | $0 | PHASE I PROJECT TITLED, DEXAMETHASONE NANOTHERAPEUTICS FOR TRAUMATIC BRAIN INJURY |
| Jan 31, 2025 | 0 | $249.5K | DHA SBIR PHASE I FOR PROJECT TITLED, "DEXAMETHASONE NANOTHERAPEUTICS FOR TRAUMATIC BRAIN INJURY" |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.